In this review we look at recent developments in the pathology of the
uterine body. Factors influencing the growth of leiomyomas are evaluat
ed together with response to medical therapy and consequent histopatho
logical changes. Further work on carcinosarcomas tends to support the
common stem-cell theory of origin, which may also be true of other sar
comas, as common chromosomal abnormalities have been found. There has
been continued work on prognostic factors in endometrial carcinomas wi
th ploidy, hormone receptor status, HER-2/neu expression, and coexiste
nt hyperplasia confirmed as independent prognostic factors, while clea
r cell and serous papillary carcinomas are confirmed as poor prognosti
c types. Finally, recent 'tumors' associated with tamoxifen are review
ed.